Jeff Lotz

Equibles does not estimate personal net worth.

Get an email with a short summary when Cytokinetics Inc publishes a filing, an earnings call transcript or a press release.

Get CYTK alerts

About Jeff Lotz

Jeff Lotz has spoken on 1 investor event across 1 company, most recently for Cytokinetics Inc on November 10, 2026. Cytokinetics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Cytokinetics Inc includes Robert Blum (CEO), Robert I. Blum (CEO and Board Member), John T. Henderson, M.D. (Chairman) and 7 others.

Jeff Lotz on recent calls

“So we're seeing, obviously, an expansion of prescribers and then increased productivity in each one of those trialists that start up. The primary drivers are... A differentiated clinical profile, you know, which directly translates into a REMS that is, I guess, less burdensome on a comparative basis.”

Other, Stifel 2026 Healthcare Conference · November 10, 2026

Affiliation history

Cytokinetics Inc (CYTK)
Transcript header (unverified)

Current

Company network

Cytokinetics Inc

CYTK

Current role

Biotechnology · Healthcare

1 appearance Latest appearance 2026-11-10

View calls and events

Leadership on record at Cytokinetics Inc

Robert Blum CEO
Robert I. Blum CEO, Board Member
John T. Henderson, M.D. Chairman
Sung H. Lee CFO
Brett Pletcher General Counsel
Jeffrey J. Hessekiel General Counsel
Mark A. Schlossberg General Counsel
Mr. Schlossberg General Counsel
Mr. Wong Chief Accounting Officer
Robert Wong Chief Accounting Officer

Recent activity

Conference Stifel 2026 Healthcare Conference Cytokinetics Inc (CYTK)
2026-11-10